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INTRODUCTION
Pediatric Gastroenterology encompasses
one of the broadest pediatric subspecial-
ities. Areas of interest include luminal
conditions, hepatology, pancreatic dis-
eases, and nutritional disorders, along
with interactions between these (such as
luminal disorders disrupting nutrition).
Furthermore, pediatric gastroenterology
services regularly intersect with almost all
other subspecialities.
Pediatric gastroenterology faces many
different challenges. These include the
type and character of the conditions cared
for, the changing patterns of conditions
over time, new developments and tech-
nologies, and expanding knowledge. Some
of these particular challenges will be high-
lighted here.
CHRONIC OR INCURABLE CONDITIONS
Many of the important conditions cared
for by pediatric gastroenterologists are
chronic or incurable, and impact not just
during the child’s initial years but through-
out their adult life as well. Management
strategies for these conditions need
to encompass broad multidisciplinary
approaches, with an emphasis upon opti-
mal care in the short-term and enhanced
outcomes in the long-term. Whilst pro-
viding consistent high-quality, child and
family-focused care is important, the
introduction of new treatments and the
promise of future cure provide ongo-
ing challenges. The inflammatory bowel
diseases are examples of such conditions.
The inflammatory bowel diseases
comprise Crohn disease (CD) and ulcer-
ative colitis (UC), with some individuals
initially categorized as IBD unclassified
(1). Increasing rates of IBD have been seen
in many areas of the world. Australasian
data show greater than 10-fold increases in
rates of CD and UC in recent years (2, 3).
High rates have been seen in individuals
migrating from the Indian subconti-
nent to industrialized countries, such as
Canada (4). More recent data also show
increased rates of IBD in locations where
this condition was previously thought to
be rare (5).
These changes in the patterns of IBD
mean that many more children are being
diagnosed and consequently require man-
agement. At present these conditions
remain incurable. Optimization of man-
agements, with focused multi-disciplinary
care within IBD teams is essential to ensure
enhanced outcomes. Given the multiple
overlapping aspects of IBD in children it is
not conceivable that a single practitioner
could provide all the elements required
for optimal care. Along with pediatric
gastroenterologists, dietitians, IBD nurses,
psychologists, and surgeons are all key
members of an IBD team.
Interventions are used in pediatric
IBD to induce and then maintain remis-
sion. The enhancement or refinement
of older, established therapies is impor-
tant to maximize the efficacies of these
approaches. This includes defining the
best ways to use particular drugs such
as aminosalicylates and thiopurines. It
also includes increasing recognition of
the important role that exclusive enteral
nutrition plays in the management of
active CD (6). However, the develop-
ment and assessment of new therapies
also remains critical. The therapeutic chal-
lenges include considering the best treat-
ment at the right time, and developing
individualized approaches for particular
patients.
In recent years there has been a
dramatic expansion in IBD-related knowl-
edge. The development of new technolo-
gies has lead to huge advances in our
understanding of the role of genetic muta-
tions in the pathogenesis of IBD (7).
Furthermore, new molecular techniques,
including high throughput sequencing,
has permitted a new wave of studies focus-
ing upon the gastrointestinal microflora,
helping us to better understand the
role of bacterial agents in the onset of
gut inflammation (8). However, there
remain many gaps in our knowledge and
understanding, requiring ongoing focused
research endeavors.
Many of the recent advances have
reflected the combined efforts of many
individuals and many groups working
together. Collaborative endeavors will be
absolutely critical in the coming years, to
ensure ongoing acquisition of new knowl-
edge and understanding. Similar collab-
orative measures will also be essential to
ensure that any new developments trans-
late to improved care and enhanced out-
comes.
EVOLVING CONDITIONS
A number of conditions commonly cared
for by pediatric gastroenterologists have
evolved and changed in recent years:
physicians must be able to adapt, learn
and change with the new developments.
Eosinophilic esophagitis and coeliac dis-
ease are just two examples.
Over the last couple of decades there
have been huge changes in our approach
to oesophageal eosinophilia, with the rise
and rise of eosinophilic oesphagitis so
that this is now an increasingly common
entity. A landmark report was published
late last century reporting a group of 10
young children presenting with upper
gut symptoms associated with marked
oesophageal eosinophilia that was unre-
sponsive to acid suppression (9). The
introduction of hypoallergenic formulae
led to prompt improvement in symp-
toms and/or resolution of the mucosal
eosinophilia. Subsequently, many cen-
ters have reported large increases in the
prevalence of this condition. Management
approaches have evolved, with the guid-
ance of key consensus statements (10).
However, there remains much to learn
about this condition, especially with
regards the long-term outcomes and
optimal management approaches.
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In recent years there have been a num-
ber of changes relating to coeliac disease:
these will continue to challenge us in the
coming years. The presentation patterns
of this condition have changed. More and
more children are now diagnosed with
atypical symptoms ormaybe no symptoms
at all, with fewer children diagnosed with
classical features of malabsorption (11).
This in part relates to the advent of screen-
ing practices in settings of increased risk,
such as Down syndrome and type 1 dia-
betes mellitus (12).
Increasing rates of coeliac disease have
been noted in several areas of the world.
Data from Finland suggest that the inci-
dence of coeliac disease in that country is
now almost 2% (13), whilst annual rates of
diagnosis in children in one pediatric cen-
ter in New Zealand have increased more
than 10-fold in the last 15 years (Day et al.,
unpublished observations).
In addition, our understanding of
the pathogenesis of coeliac disease has
expanded greatly. New diagnostic tools
have been developed and assessed. Very
recently, a new approach to the diagnosis
of coeliac disease has emerged (14). These
protocols developed in Europe encom-
pass clinical and biochemical assessments
to reach a diagnosis, with exclusion of
a requirement for endoscopic biopsies
in many children. However, the appli-
cation of these approaches may not be
suitable in other areas of the world,
such as Australasia and North America.
Further focused studies are required to
ensure that such protocols are universally
appropriate. Clearly achieving a robust
and clear diagnosis is important: the use
of non-invasive tests to establish this
has many potential advantages, including
cost, resource implications, and parental
distress. None-the-less, the development
of improved and enhanced diagnostic
approaches should lead to earlier andmore
effective diagnosis of this condition in
children.
Furthermore, as we understand more
about the pathogenesis of coeliac disease,
it has become clear that there are a num-
ber of potential strategies by which these
pathways could be interrupted (15). One
very promising example is the develop-
ment of vaccine-based treatment currently
undergoing clinical trials in several coun-
tries (www.immunsant.com). This novel
immune-based strategy promises to lead
to a new approach to the treatment of
coeliac disease. Namely, the introduction
of a vaccine will mean that individu-
als diagnosed with coeliac disease who
are then treated with the vaccine, will
subsequently be able to tolerate a gluten-
containing diet, without need for gluten-
free diet. This promise of a cure for coeliac
disease could transform the limitations of
coeliac disease, and make huge differences
in the lives of many children and fam-
ilies. However, this approach is still the
“ambulance at the bottom of the cliff.” The
development of effective and safe preven-
tative strategies may be even more impor-
tant and have greater impact. One exam-
ple of such an approach is the timing of
introduction of gluten-containing foods in
infancy (16). Introduction of these cere-
als during breast-feeding in mid-infancy
appears to the best approach, but further
studies are focusing upon this.
Although new diagnostic protocols may
facilitate quicker diagnosis of coeliac dis-
ease in children, a number of aspects of
this condition remain unclear and require
further study. It is likely that coeliac dis-
ease will continue to provide challenges for
pediatric gastroenterologists in the future.
SOCIETAL CHANGES LEADING TO NEW
CHALLENGES
Several current social changes also impact
greatly and provide further important
challenges to pediatric gastroenterologists.
Increasing rates of childhood obesity have
been seen in many parts of the world (17).
Although initially thought of as a conse-
quence of the developed world, increasing
rates are also now seen in developing coun-
tries.
Higher rates of childhood obesity have
led to increased rates of non-alcoholic
fatty liver disease (18). These changes have
significant implications during childhood
and also for future adult years. This condi-
tion has become an increasingly common
indication for liver transplant, which con-
sequently leads to a further set of long-
term health issues.
WORKFORCE CHALLENGES
The changing patterns and increasing
patient load consequent to many of
the developments mentioned above have
potential huge implications for resources
in many countries around the world.
Several workforce assessments have been
conducted in North America: these esti-
mate a workforce of around nine pediatric
gastroenterologists per million children at
that time (19, 20). Variations were seen
between states in the USA and provinces
in Canada. The current workforce in NZ
is half of that seen in North America (4.5
pediatric gastroenterologists/million chil-
dren), with consequent workload implica-
tions. However, the numbers of physicians
need to be balanced also with other key
staff providing care for these children—
including dietitians and psychologists.
In some parts of the world, pediatric
gastroenterology services have been cov-
ered by adult gastroenterology services or
by general pediatricians. Dedicated and
well-trained personnel ready to face the
challenges faced by pediatric gastroen-
terologists, and able to provide high-
quality child and family-friendly services
are essential.
Endoscopy services are a particular
illustration of the importance of this
important concept. Pediatric endoscopy
services should be provided by endo-
scopists with specific training in pediatric
conditions and approaches (21). Children
are not just little adults and reflect dif-
ferent conditions and different manifes-
tations. Child friendly facilities are a fur-
ther important aspect—not just for pre-
schoolers with play-areas, but also for
adolescents. The benefits of these con-
siderations have not been illustrated in
an evidence based fashion, but do appear
implicit and self-evident.
CONCLUSIONS
Many issues face pediatric gastroenterol-
ogy now and many more will face the
discipline in the coming years. Pediatric
gastroenterology services include condi-
tions affecting the length and breadth of
the gut, along with impact upon many
other systems. The spectrum of condi-
tions managed and the incidence of many
key conditions are both changing rapidly
and dramatically: many of these changes
are expected to continue apace. Pediatric
gastroenterologists must be equipped with
the skills and opportunities to be able to
face and overcome these present challenges
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as well as the new challenges around the
corner.
Numerous clinical, outcomes and
laboratory-based research endeavors
are now required to answer the many
outstanding questions and to provide
opportunities to overcome these chal-
lenges. Collaborative and multi-center
population-based initiatives will be
required to advance understanding of
the epidemiology and natural history of
many pediatric gastroenterology condi-
tions. The development and assessment of
new diagnostic tools and markers would
ensure optimization of initial assessment
and on-going management. Furthermore,
other endeavors should focus on advanc-
ing our understanding of the pathogenesis
of specific conditions, providing impetus
to finding cures. In conclusion, together,
we must take up the call to answer these
key questions so that we can overcome the
challenges facing us.
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